Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Cylindrospermopsin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00905
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cyanotoxin |
DME Modulation |
Cylindrospermopsin inhibits the expression of DME GSTA2 |
[1] |
Azaspiracid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01502
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Marine Algal Toxin |
DME Modulation |
Azaspiracid inhibits the expression of DME GSTA2 |
[2] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the expression of DME GSTA2 |
[3] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 inhibits the expression of DME GSTA2 |
[4], [5] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Iprodione |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00851
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health and Environmental Toxicant |
DME Modulation |
Iprodione up-regulates the expression of DME GSTA2 |
[6] |
Butyraldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00999
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Butyraldehyde inhibits the expression of DME GSTA2 |
[7] |
Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME GSTA2 |
[8] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Bilirubin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00877
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Bilirubin up-regulates the expression of DME GSTA2 |
[9] |
Indolo(3,2-B)carbazole |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01343
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Indolo(3,2-B)carbazole inhibits the expression of DME GSTA2 |
[3] |
Isoimperatorin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01554
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Isoimperatorin up-regulates the expression of DME GSTA2 |
[10] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME GSTA2 |
[11] |
Ketoconazole |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00251
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Ketoconazole inhibits the expression of DME GSTA2 |
[12] |
Leflunomide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Leflunomide inhibits the expression of DME GSTA2 |
[13] |
Phenobarbital |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00410
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Phenobarbital inhibits the drug-metabolizing activity of DME GSTA2 |
[14] |
Urethane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Urethane inhibits the expression of DME GSTA2 |
[15] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Diethyltoluamide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00582
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Diethyltoluamide up-regulates the expression of DME GSTA2 |
[16] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Lactacystin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01362
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2/3 |
DME Modulation |
Lactacystin up-regulates the expression of DME GSTA2 |
[17] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
K-7174 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 inhibits the expression of DME GSTA2 |
[18] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
MG-132 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01219
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
MG-132 up-regulates the expression of DME GSTA2 |
[17] |
|
|
|
|
|
|